Simvastatin in the elderly

Author: zjuh

August undefined, 2024

Webb24 jan. 2024 · The elderly suffer not only more advanced and complex changes of cardiovascular system but, also, other chronic conditions. Moreover, compared to middle-age, different therapeutic response is often observed due to changes of pharmaco-kinetics and -dynamics; these patients use other medications, which may trigger drug interactions. WebbA study indirectly compared influence of atorvastatin, pravastatin and simvastatin on the cerebrovascular events (CVEs), but it was a placebo-control study with a small sample size and there were active comparator trials in this study. 7 The network meta-analysis was conducted to evaluate the RCT that investigated the effects of primary and secondary …

Advances in Diabetes for the Millennium: Diabetes and Cholesterol

WebbSimvastatin tablets are an HMG-CoA reductase inhibitor indicated: To reduce the risk of total mortality by reducing risk of coronary heart disease death, non-fatal myocardial infarction and stroke, and the need for coronary and non-coronary revascularization procedures in adults with established coronary heart disease, cerebrovascular disease, … Webb1 apr. 2024 · Simvastatin belongs to the group of medicines called HMG-CoA reductase inhibitors, or statins. It works to reduce the amount of cholesterol in the blood by … iaczc datasheet

Många äldre har biverkningar av simvastatin

Webb26 nov. 2024 · Background: There is widespread consumer concern that statin use may be associated with impaired memory and cognitive decline. Objectives: This study sought to examine the association between statin use and changes in memory and global cognition in the elderly population over 6 years and brain volumes over 2 years. . Interactions … WebbInformation on the lipid-lowering efficacy of pitavastatin in elderly patients comes either from subgroup analysis of age-diverse studies 19,20 or those performed specifically in older adults. 21–23 A Phase 3, randomized, double-blind, parallel-group, active-controlled study of 355 patients by Eriksson et al compared pitavastatin (4 mg/day) to simvastatin … Webb2 feb. 2024 · Overall, statin or more intensive therapy yielded a 24% (RR 0·76, 95% CI 0·73–0·79) proportional reduction in major coronary events per 1·0 mmol/L reduction in … ia cyber securityrelated duties

Cholesterol Drugs for People 75 and Older Choosing Wisely

Overuse of Statins in Older Adults AAFP

Webb30 okt. 2024 · In elderly people, the benefits and disadvantages of the treatment with statins should be put in balance, especially in those receiving high doses of statins. … Webb1 feb. 1994 · Twenty elderly patients (14 women, 6 men) with primary hypercholesterolemia (total cholesterol >260 mg/dl) were treated for 42 months with simvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor. Mean age was 69 ± 3 years (range, 65 to 72 years). molson coors super bowl draftkingsWebb1 okt. 2024 · The primary outcomes include dementia and physical disability over 4 years. Meanwhile, the STAREE trial will assess the efficacy of atorvastatin 40 mg daily versus placebo in the improvement of overall survival or disability-free survival in 18,000 … ia cyber awareness certificate

"Webb12 apr. 2024 · Moderate-intensity statin with ezetimibe combination therapy was associated with lower rates of intolerance-related drug discontinuation or dose reduction among patients aged ≥75 years (2.3% vs. 7.2%; p = 0.010) and those aged <75 years (5.2% vs. 8.4%; p < 0.001) (p for interaction = 0.159). Median LDL-C levels were 58 mg/dL in the ... " - Simvastatin in the elderly

Simvastatin in the elderly

Simvastatin (Oral Route) Side Effects - Mayo Clinic

Webb2 okt. 2024 · Statin drugs have been shown to reduce the risk of cardiovascular disease (CVD) in young and middle-aged adults. With older adults (those 75 and over), the benefits are less clear. But a recent study published in the European Heart Journal suggests that there is in fact a benefit to statin use in this older population. WebbSimvastatin in the treatment of hypercholesterolemia in elderly patients Twenty elderly (mean age, 69 years), hypercholesterolemic patients (low-density lipoprotein [LDL] levels greater than or equal to 160 mg/dl) were supplied a lipid-lowering diet for one month and then received 10 mg of simvastatin daily for 12 months.

Did you know?

Webb29 okt. 2024 · Similarly, an Israeli study, also published in 2024, in the Journal of the American Geriatrics Society, found that older people who adhered to their statin prescription had a 34 percent lower chance of an early death from any cause than those who stopped taking the drug. Webb10 mars 2015 · In patients under the age of 75, the efficacy of statins for primary prevention is well-established on the basis of multiple randomized trials, which have found that they reduce the relative risk of major vascular events by 20-30%. 3,4 The relative benefits of statins are consistent across multiple subgroups and similar for patients at …

WebbSimvastatin is an HMG-CoA reductase inhibitor (statin) indicated as an adjunctive therapy to diet to: • Reduce the risk of total mortality by reducing CHD deaths and reduce the risk of non-fatal myocardial infarction, stroke, and the need for revascularization procedures in patients at high risk of coronary events.1.1 Webb19 nov. 2024 · The finding that statins are not associated with an accelerated rate of memory and cognitive decline in elderly patients is reassuring given an aging population, the societal implications of dementia, and frequency of statin use.

WebbCutaneous adverse reactions were also observed for hydrochlorothiazide, atorvastatin, simvastatin, telmisartan, and metformin. ... Among the elderly population, the majority (59%) are women. Their proportion even increases with subsequent age groups: eg, in the group aged 65–69, the proportion of women is 55%; this increases to 58% at age ... WebbManaging hypercholesterolemia and preventing cardiovascular events in elderly and younger Chinese adults: focus on rosuvastatin Zhen Wang, Junbo GeDepartment of …

Webb4 feb. 2024 · Statin therapy is safe in the elderly and has no effect at any age on nonvascular mortality, cancer death, or cancer incidence. In persons >75 years, the absolute reduction in vascular events was about 0.5% per year per mmol/L decrease in LDL-C, which may or may not be greater in high-risk subjects.

WebbThe authors treated a group of elderly patients with Simvastatin (20 mg/day for 1 year), a HMG CoA reductase inhibitor and observed a significant reduction in total cholesterol (p … iad007-epms-01a/citectWebb1 apr. 2024 · Proper Use. Take this medicine only as directed by your doctor. Do not use more of it, do not use it more often, and do not use it for a longer time than your doctor ordered. Take this medicine on the evening, on an empty stomach. Shake the oral suspension well for at least 20 seconds before using it. Use a marked measuring spoon, … iacx gathering llcWebb31 maj 2024 · Simvastatin is a prescription drug. It comes in two forms: a tablet and a suspension. Both forms are taken by mouth. Simvastatin oral tablet is available as the … ia cyber awareness certificate armyWebbthere seems no controversy in initiation of statins in patients for primary prevention up to 80 years of age. Elderly people are at highest risk of cardiovascular morbidity and … iad012-bms-01aWebb19 apr. 2024 · There is some debate on the value of statins in people over 75 years old, especially for primary prevention of CV events, due to a lack of evidence of their efficacy … iad130-eaton-01/webviewsWebb2 jan. 2024 · Recommended statins based on low-density lipoprotein cholesterol (LDL-C) before treatment is 70-189 mg/dl in the age range of 40-75 years in the ACC/AHA who … iad009-bms-01aWebb30 mars 2024 · Scandinavian Simvastatin Survival Study group Randomized controlled trial of cholesterol lowering in 4444 patients with ... Alacqua M, Corrao S, Tari M, Arcoraci V. Statins for the primary prevention of cardiovascular events in elderly patients: a picture from clinical practice without strong evidence from clinical trials. J ... iad1-plapp-01/citect/